These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28560570)

  • 1. Effect of Lorenzo's Oil on Hepatic Gene Expression and the Serum Fatty Acid Level in abcd1-Deficient Mice.
    Morita M; Honda A; Kobayashi A; Watanabe Y; Watanabe S; Kawaguchi K; Takashima S; Shimozawa N; Imanaka T
    JIMD Rep; 2018; 38():67-74. PubMed ID: 28560570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lorenzo's oil inhibits ELOVL1 and lowers the level of sphingomyelin with a saturated very long-chain fatty acid.
    Sassa T; Wakashima T; Ohno Y; Kihara A
    J Lipid Res; 2014 Mar; 55(3):524-30. PubMed ID: 24489110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?
    Cappa M; Bizzarri C; Giannone G; Aiello C; Di Biase A
    J Endocrinol Invest; 2011 Nov; 34(10):753-6. PubMed ID: 21399389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
    Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
    J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect.
    Deon M; Garcia MP; Sitta A; Barschak AG; Coelho DM; Schimit GO; Pigatto M; Jardim LB; Wajner M; Giugliani R; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):43-9. PubMed ID: 18026827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of very long-chain fatty acids levels in X-linked adrenoleukodystrophy, treated with haematopoietic stem cell transplantation and Lorenzo's Oil.
    Stradomska TJ; Drabko K; Moszczyńska E; Tylki-Szymańska A
    Folia Neuropathol; 2014; 52(2):159-63. PubMed ID: 25118901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
    Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
    Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Lorenzo's Oil on peroxisomes in healthy mice.
    De Craemer D; Van den Branden C; Fontaine M; Vamecq J
    Prostaglandins Other Lipid Mediat; 1998 Mar; 55(4):237-44. PubMed ID: 9644114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
    Kruska N; Schönfeld P; Pujol A; Reiser G
    Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis.
    Schackmann MJ; Ofman R; Dijkstra IM; Wanders RJ; Kemp S
    Biochim Biophys Acta; 2015 Feb; 1851(2):231-7. PubMed ID: 25499606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
    Street JM; Singh H; Poulos A
    Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain microsomal fatty acid elongation is increased in abcd1-deficient mouse during active myelination phase.
    Morita M; Kawamichi M; Shimura Y; Kawaguchi K; Watanabe S; Imanaka T
    Metab Brain Dis; 2015 Dec; 30(6):1359-67. PubMed ID: 26108493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoleukodystrophy: magnetic resonance follow-up after Lorenzo's oil therapy.
    Duchesne N; Dufour M; Bouchard G; Grondin P; Lemieux B
    Can Assoc Radiol J; 1995 Oct; 46(5):386-91. PubMed ID: 7552831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling and Imaging of Phospholipids in Brains of Abcd1-Deficient Mice.
    Hama K; Fujiwara Y; Morita M; Yamazaki F; Nakashima Y; Takei S; Takashima S; Setou M; Shimozawa N; Imanaka T; Yokoyama K
    Lipids; 2018 Jan; 53(1):85-102. PubMed ID: 29469952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked Adrenoleukodystrophy in a 20-Year-Old Male With an ABCD1 Gene Mutation: First Case From Pakistan.
    Ghori M; Molani RA; Ibrahim PMN; Hanif MI; Jamal Raza J
    Cureus; 2022 Feb; 14(2):e21837. PubMed ID: 35291541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary Lorenzo's oil and docosahexaenoic acid treatment for Zellweger syndrome.
    Arai Y; Kitamura Y; Hayashi M; Oshida K; Shimizu T; Yamashiro Y
    Congenit Anom (Kyoto); 2008 Dec; 48(4):180-2. PubMed ID: 18983586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.